NCBiotech Supports Proposed Legislation To Strengthen US Biomanufacturing

By Chris Capot, NCBiotech

A new bipartisan bill, the Biomanufacturing Excellence Act, aims to position the U.S. as a global leader in biopharmaceutical manufacturing. The legislation would create a National Biopharmaceutical Manufacturing Center of Excellence, designed to strengthen domestic innovation, reduce reliance on foreign supply chains, and expand access to advanced medicines. This initiative emphasizes collaboration among industry, academia, and government to accelerate technology development, ensure supply chain resiliency, and train a skilled workforce. With endorsements from leading biotech organizations, the bill reflects growing recognition that biomanufacturing is critical to national security, public health, and economic competitiveness.

Learn how this proposed center could transform U.S. biopharma manufacturing and secure leadership in life-saving innovation.